CompanyDrug

Akeso Biopharma Files New Indication for Penpulimab in First-Line NPC Treatment

CompanyDeals

SanegeneBio Secures Over USD 80 Million in Series A+ Funding to Advance RNAi Therapeutics

CompanyDrug

Shanghai Junshi’s Loqtorzi Enters Australian Market Approval Process for Nasopharyngeal Carcinoma

CompanyDrug

CARsgen Therapeutics Secures U.S. FDA Approval for CT071 Clinical Trials in Multiple Myeloma

CompanyDrug

Lepu Biotechnology’s MRG003 Gains Fast-Track Status from U.S. FDA for Nasopharyngeal Carcinoma

CompanyDeals

Nona Biosciences Partners with Lycia Therapeutics to Advance LYTAC Platform for Novel Therapies

CompanyDeals

Concentra Biosciences Targets China-Based Biotech LianBio in Unsolicited Takeover Bid

Medical DevicePolicy / Regulatory

FDA Investigates Safety of China-Made Plastic Syringes Due to Quality Concerns

Policy / Regulatory

China’s State Council Unveils Comprehensive Plan to Boost Beijing’s Healthcare Sector

CompanyDeals

Bayer Partners with CrossBay Medical to Enhance Hormonal IUS Delivery System

CompanyDeals

Johnson & Johnson Acquires Laminar for $400 Million to Enhance Heart Rhythm Solutions

CompanyDrug

Yingli Pharma Enrolls First Patient in Phase I Study for KRAS Inhibitor YL-17231 at MD Anderson